J W Karuru1, G N Lule, M Joshi, O Anzala. 1. Department of Internal Medicine, College of Health Sciences, University of Nairobi, P.O. Box 19676, Nairobi, Kenya.
Abstract
OBJECTIVE: To determine the prevalence of HCV infection and HCV/HIV co-infection among voluntary blood donors at the National Blood Transfusion Centre and clients at the Kenyatta National Hospital HIV-Voluntary Counseling and Testing (VCT) Centre. DESIGN: A prospective cross-sectional descriptive study. SETTING: Kenyatta National Hospital, a tertiary referral and teaching hospital and the National Blood Transfusion Services Centre, Nairobi. SUBJECTS: Volunteer blood donors and VCT attendants. RESULTS: The prevalence of HCV/HIV co-infection among 6154 blood donors in the NBTSC was very low, at 0.02. The HIV prevalence among the 353 KNH HIV-VCT clients was 9.3%, none of the clients tested positive for HCV. The incidence of risk factors in the persons with HCV and/or HIV infection(s) was low. CONCLUSION: The prevalence of HCV infection among pre-screened volunteer blood donors was low. However the current practice of screening all donated blood for HCV remains indispensable to prevent its transmission to blood recipients.
OBJECTIVE: To determine the prevalence of HCV infection and HCV/HIV co-infection among voluntary blood donors at the National Blood Transfusion Centre and clients at the Kenyatta National Hospital HIV-Voluntary Counseling and Testing (VCT) Centre. DESIGN: A prospective cross-sectional descriptive study. SETTING: Kenyatta National Hospital, a tertiary referral and teaching hospital and the National Blood Transfusion Services Centre, Nairobi. SUBJECTS: Volunteer blood donors and VCT attendants. RESULTS: The prevalence of HCV/HIV co-infection among 6154 blood donors in the NBTSC was very low, at 0.02. The HIV prevalence among the 353 KNH HIV-VCT clients was 9.3%, none of the clients tested positive for HCV. The incidence of risk factors in the persons with HCV and/or HIV infection(s) was low. CONCLUSION: The prevalence of HCV infection among pre-screened volunteer blood donors was low. However the current practice of screening all donated blood for HCV remains indispensable to prevent its transmission to blood recipients.
Authors: Calleb George Onyango; Lilian Ogonda; Bernard Guyah; Peter Okoth; Clement Shiluli; Felix Humwa; Vallarie Opollo Journal: BMC Res Notes Date: 2018-03-12
Authors: Essa A Mohamed; Nasra H Giama; Abubaker O Abdalla; Hassan M Shaleh; Abdul M Oseini; Hamdi A Ali; Fowsiyo Ahmed; Wesam Taha; Hager Ahmed Mohammed; Jessica Cvinar; Ibrahim A Waaeys; Hawa Ali; Loretta K Allotey; Abdiwahab O Ali; Safra A Mohamed; William S Harmsen; Eimad M Ahmmad; Numra A Bajwa; Mohamud D Afgarshe; Abdirashid M Shire; Joyce E Balls-Berry; Lewis R Roberts Journal: World J Gastroenterol Date: 2022-09-21 Impact factor: 5.374
Authors: Missiani Ochwoto; James H Kimotho; Julius Oyugi; Fredrick Okoth; Henry Kioko; Simeon Mining; Nancy L M Budambula; Elizabeth Giles; Anton Andonov; Elijah Songok; Carla Osiowy Journal: BMC Infect Dis Date: 2016-03-01 Impact factor: 3.090
Authors: Essa A Mohamed; Nasra H Giama; Hassan M Shaleh; Linda Kerandi; Abdul M Oseini; Hager Ahmed Mohammed; Henry Kerandi; Loretta K Allotey; Ibrahim A Waaeys; Hamdi A Ali; Hawa M Ali; Safra A Mohamed; Ju Dong Yang; Wudneh O Gaga; Lily L Tamire; Awol Windissa; Christi A Patten; Joyce E Balls-Berry; Lewis R Roberts Journal: Front Public Health Date: 2020-03-06